Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Recent Study: Cataract - Pipeline Review, H2 2013


Print article Print article
2013-12-22 17:01:05 - Fast Market Research recommends "Cataract - Pipeline Review, H2 2013" from Global Markets Direct, now available

Global Markets Direct's, 'Cataract - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cataract, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cataract. Cataract - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Full Report Details at

- www.fastmr.com/prod/755164_cataract_pipeline_review_h2_2013.aspx

Scope

* A snapshot of the global therapeutic scenario for Cataract.
* A review of the Cataract products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Cataract pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Cataract.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Cataract pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned in this Report: Laboratorios Sophia S.A. de C.V., Laila Pharmaceuticals Pvt. Ltd.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Cataract Overview
Therapeutics Development
An Overview of Pipeline Products for Cataract
Cataract Therapeutics under Development by Companies
Cataract Therapeutics under Investigation by Universities/Institutes
Mid Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Cataract Therapeutics - Products under Development by Companies
Cataract Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Cataract Therapeutics Development
Laboratorios Sophia S.A. de C.V.
Laila Pharmaceuticals Pvt. Ltd.
Cataract - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
dexamethasone acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MTP-131 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PRO-155 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
caffeic acid phenethyl ester - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LP-013-09 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug For Cataract - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cataract Therapeutics - Drug Profile Updates
Cataract Therapeutics - Discontinued Products
Cataract Therapeutics - Dormant Products
Cataract - Product Development Milestones
Featured News & Press Releases
Apr 30, 2013: Omeros Ophthalmology Product OMS302 Granted Eligibility For European Centralized Review
Nov 29, 2011: Omeros Submits Paediatric Investigation Plan Letter Of Intent For OMS302 To European Medicines Agency
Oct 11, 2011: Omeros Announces First Patients Treated In Phase III Clinical Program Evaluating OMS302
May 19, 2011: Omeros Advances OMS302 Into Phase III Clinical Development Program
Mar 23, 2011: Omeros's Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase IIb Clinical Study
Mar 22, 2011: InSite Vision Announces Positive Phase I/II Results For ISV-303 For Reduction Of Pain And Inflammation After Cataract Surgery
Jan 05, 2011: InSite Vision Completes Patient Enrollment In ISV-303 Phase I/II Clinical Study For Post-Surgical Ocular Pain And Swelling
Aug 23, 2010: InSite Vision Initiates Phase I/II Clinical Study Of ISV-303 For Post-Surgical Ocular Pain And Swelling
Jul 27, 2010: Omeros Initiates Phase IIb Clinical Trial For OMS302 In Patients Undergoing Cataract Surgery
Jan 05, 2010: Icon Bioscience Initiates Phase II/III Pivotal Clinical Study Of Novel Ophthalmic Drug Candidate IBI-10090
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Cataract, H2 2013
Products under Development for Cataract - Comparative Analysis, H2 2013
Number of Products under Development by Companies, H2 2013
Number of Products under Investigation by Universities/Institutes, H2 2013

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=755164&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser